{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T13:06:06Z","timestamp":1795093566634,"version":"4.10.2"},"reference-count":48,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"am","delay-in-days":380,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.vaccine.2021.05.061","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T08:30:00Z","timestamp":1622536200000},"page":"3916-3925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Optimising HPV vaccination communication to adolescents: A discrete choice experiment"],"prefix":"10.1016","volume":"39","author":[{"given":"Sandra","family":"Chyderiotis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Sicsic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Raude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7384-9828","authenticated-orcid":false,"given":"Isabelle","family":"Bonmarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Jeanleboeuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Le Duc Banaszuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Gauchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Bruel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6090-8211","authenticated-orcid":false,"given":"Morgane","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Giraudeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Thilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith E.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2021.05.061_b0005","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/2229-516X.179027","article-title":"Human papillomavirus-associated cancers: A growing global problem","volume":"6","author":"Bansal","year":"2016","journal-title":"Int J Appl Basic Med Res."},{"key":"10.1016\/j.vaccine.2021.05.061_b0010","article-title":"R\u00e9seau fran\u00e7ais des registres de cancers Francim. Cancer du col de l\u2019ut\u00e9rus en France : tendances de l\u2019incidence et de la mortalit\u00e9 jusqu\u2019en 2018","author":"Hamers","year":"2019","journal-title":"Bull Epid\u00e9miol Hebd [Internet]"},{"key":"10.1016\/j.vaccine.2021.05.061_b0015","unstructured":"Institut national du cancer. Les cancers en France - Les donn\u00e9es - Edition 2015 [Internet]. Boulogne; 2015. Available from: www.e-cancer.fr"},{"key":"10.1016\/j.vaccine.2021.05.061_b0020","doi-asserted-by":"crossref","unstructured":"Garland SM, Kjaer SK, Mu\u00f1oz N, Block SL, Brown DR, Dinubile MJ, et al. Impact and effectiveness of the quadrivalent human papillomavirus vaccine: A systematic review of 10 years of real-world experience [Internet]. Vol. 63, Clinical Infectious Diseases. 2016 [cited 2020 Apr 20]. p. 519\u201327. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27230391","DOI":"10.1093\/cid\/ciw354"},{"issue":"14","key":"10.1016\/j.vaccine.2021.05.061_b0025","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV Vaccination and the Risk of Invasive Cervical Cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med [Internet]"},{"key":"10.1016\/j.vaccine.2021.05.061_b0030","unstructured":"Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9. Le calendrier des vaccinations 2020 [Internet]. 2020 [cited 2020 Apr 21]. Available from: https:\/\/solidarites-sante.gouv.fr\/prevention-en-sante\/preserver-sa-sante\/vaccination\/calendrier-vaccinal"},{"key":"10.1016\/j.vaccine.2021.05.061_b0035","first-page":"424","article-title":"\u00c9volution de la couverture vaccinale du vaccin contre le papillomavirus en France \u2013 2008\u20132018","volume":"22\u201323","author":"Fonteneau","year":"2019","journal-title":"Bull Epid\u00e9miol Hebd"},{"key":"10.1016\/j.vaccine.2021.05.061_b0040","doi-asserted-by":"crossref","unstructured":"Sheikh S, Biundo E, Courcier S, Damm O, Launay O, Maes E, et al. A report on the status of vaccination in Europe. Vol. 36, Vaccine. Elsevier Ltd; 201p. 4979\u201392.","DOI":"10.1016\/j.vaccine.2018.06.044"},{"key":"10.1016\/j.vaccine.2021.05.061_b0045","doi-asserted-by":"crossref","unstructured":"Nguyen-Huu N-H, Thilly N, Derrough T, Sdona E, Claudot F, Pulcini C, et al. Human papillomavirus vaccination coverage, policies, and practical implementation across Europe. Vaccine [Internet]. 2020 Feb;38(6):1315\u201331. Available from: https:\/\/doi.org\/10.1016\/j.vaccine.2019.11.081","DOI":"10.1016\/j.vaccine.2019.11.081"},{"issue":"3","key":"10.1016\/j.vaccine.2021.05.061_b0050","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pvr.2017.02.004","article-title":"Loss of chance associated with sub-optimal HPV vaccination coverage rate in France","volume":"1","author":"Uhart","year":"2017","journal-title":"Papillomavirus Res"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2021.05.061_b0055","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1080\/21645515.2018.1564436","article-title":"HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe","volume":"15","author":"Karafillakis","year":"2019","journal-title":"Hum Vaccines Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2021.05.061_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2458-12-509","article-title":"Understanding attitudes toward adolescent vaccination and the decision-making dynamic among adolescents, parents and providers","volume":"12","author":"Gowda","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2021.05.061_b0065","unstructured":"Amessi L. Connaissances sur les infections g\u00e9nitales \u00e0 HPV et couverture vaccinale HPV des \u00e9l\u00e8ves d\u2019un coll\u00e8ge \u00e0 Paris. 2016."},{"key":"10.1016\/j.vaccine.2021.05.061_b0070","unstructured":"Ecollan M. Connaissances et facteurs associ\u00e9s \u00e0 la vaccination anti-HPV chez les parents des \u00e9l\u00e8ves de deux coll\u00e8ges parisiens. 2016."},{"key":"10.1016\/j.vaccine.2021.05.061_b0075","article-title":"Human papillomavirus infections: influence of perceptions of disease and vaccine on immunization status","author":"Verrier","year":"2019","journal-title":"Bull Epid\u00e9miol Hebd [Internet]"},{"issue":"20","key":"10.1016\/j.vaccine.2021.05.061_b0080","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1016\/j.vaccine.2017.03.086","article-title":"Quantifying population preferences around vaccination against severe but rare diseases: A conjoint analysis among French university students, 2016","volume":"35","author":"Seanehia","year":"2017","journal-title":"Vaccine [Internet]"},{"issue":"May","key":"10.1016\/j.vaccine.2021.05.061_b0085","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.socscimed.2018.04.038","article-title":"Individual decisions to vaccinate one\u2019s child or oneself: A discrete choice experiment rejecting free-riding motives","volume":"207","author":"Verelst","year":"2018","journal-title":"Soc Sci Med [Internet]"},{"issue":"15","key":"10.1016\/j.vaccine.2021.05.061_b0090","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.vaccine.2019.02.056","article-title":"Drivers of vaccine decision-making in South Africa: A discrete choice experiment","volume":"37","author":"Verelst","year":"2019","journal-title":"Vaccine [Internet]."},{"key":"10.1016\/j.vaccine.2021.05.061_b0095","unstructured":"Perronnin M, Louvel A. La compl\u00e9mentaire sant\u00e9 en 2014\u00a0: 5 % de non-couverts et 12 % parmi les 20 % les plus pauvres. Quest d\u2019\u00e9conomie la sant\u00e9 [Internet]. 2018;229:1\u20136. Available from: http:\/\/www.irdes.fr\/recherche\/questions-d-economie-de-la-sante\/229-la- complementaire-sante-en-2014.pdf"},{"key":"10.1016\/j.vaccine.2021.05.061_b0100","doi-asserted-by":"crossref","unstructured":"Sinka K, Kavanagh K, Gordon R, Love J, Potts A, Donaghy M, et al. Achieving high and equitable coverage of adolescent HPV vaccine in Scotland. J Epidemiol Community Health [Internet]. 2014 [cited 2020 Aug 21];68(1):57\u201363. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23986492\/","DOI":"10.1136\/jech-2013-202620"},{"issue":"41","key":"10.1016\/j.vaccine.2021.05.061_b0105","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2807\/1560-7917.ES.2018.23.41.1700737","article-title":"The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: What additional disease burden will a nonavalent vaccine prevent?","volume":"23","author":"Patel","year":"2018","journal-title":"Eurosurveillance"},{"issue":"34","key":"10.1016\/j.vaccine.2021.05.061_b0110","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1016\/j.vaccine.2015.04.039","article-title":"Addressing vaccine hesitancy: The potential value of commercial and social marketing principles and practices","volume":"33","author":"Nowak","year":"2015","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2021.05.061_b0115","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/hec.1697","article-title":"Discrete choice experiments in health economics: a review of the literature","volume":"21","author":"de Bekker-Grob","year":"2012","journal-title":"Health Econ [Internet]"},{"issue":"4","key":"10.1016\/j.vaccine.2021.05.061_b0120","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jval.2010.11.013","article-title":"Conjoint Analysis Applications in Health\u2014a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force","volume":"14","author":"Bridges","year":"2011","journal-title":"Value Heal [Internet]"},{"key":"10.1016\/j.vaccine.2021.05.061_b0125","doi-asserted-by":"crossref","unstructured":"Soekhai V, de Bekker-Grob EW, Ellis AR, Vass CM. Discrete Choice Experiments in Health Economics: Past, Present and Future. Pharmacoeconomics [Internet]. 2019 Feb 13 [cited 2020 Jul 30];37(2):201\u201326. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30392040\/","DOI":"10.1007\/s40273-018-0734-2"},{"issue":"4","key":"10.1016\/j.vaccine.2021.05.061_b0130","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0277-9536(98)00374-8","article-title":"Using conjoint analysis to take account of patient preferences and go beyond health outcomes: An application to in vitro fertilisation","volume":"48","author":"Ryan","year":"1999","journal-title":"Soc Sci Med [Internet]"},{"issue":"8","key":"10.1016\/j.vaccine.2021.05.061_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104772","article-title":"Have preferences of girls changed almost 3 years after the much debated start of the HPV vaccination program in the Netherlands? A discrete choice experiment","volume":"9","author":"Hofman","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.05.061_b0140","doi-asserted-by":"crossref","unstructured":"de Bekker-Grob EW, Hofman R, Donkers B, van Ballegooijen M, Helmerhorst TJMM, Raat H, et al. Girls\u2019 preferences for HPV vaccination: A discrete choice experiment. Vaccine [Internet]. 2010;28(41):6692\u20137. Available from: http:\/\/dx.doi.org\/10.1016\/j.vaccine.2010.08.001","DOI":"10.1016\/j.vaccine.2010.08.001"},{"key":"10.1016\/j.vaccine.2021.05.061_b0145","series-title":"Preference Measurement in Health (Advances in Health Economics and Health Services Research) [Internet]","first-page":"93","article-title":"Adolescent Girls\u2019 Preferences for HPV Vaccines: A Discrete Choice Experiment","author":"Brown","year":"2014"},{"issue":"2","key":"10.1016\/j.vaccine.2021.05.061_b0150","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.vaccine.2021.05.061_b0155","doi-asserted-by":"crossref","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: Building an international community of software platform partners. Vol. 95, Journal of Biomedical Informatics. Academic Press Inc.; 2019. p. 103208.","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"10.1016\/j.vaccine.2021.05.061_b0160","doi-asserted-by":"crossref","unstructured":"Ryan M, Watson V, Entwistle V. Rationalising the \u201cirrational\u201d: A think aloud study of discrete choice experiment responses. Health Econ [Internet]. 2009 [cited 2020 Aug 18];18(3):321\u201336. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/18651601\/","DOI":"10.1002\/hec.1369"},{"key":"10.1016\/j.vaccine.2021.05.061_b0165","doi-asserted-by":"crossref","unstructured":"Betsch C, Sachse K. Debunking vaccination myths: Strong risk negations can increase perceived vaccination risks. Heal Psychol [Internet]. 2013 [cited 2015 Sep 1];32(2):146\u201355. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22409264","DOI":"10.1037\/a0027387"},{"key":"10.1016\/j.vaccine.2021.05.061_b0170","unstructured":"Mansfield C, Sutphin J, Boeri M. Assessing the impact of excluded attributes on choice in a discrete choice experiment using a follow\u2010up question. Health Econ [Internet]. 2020 Jul 6 [cited 2020 Aug 18];hec.4124. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/hec.4124"},{"key":"10.1016\/j.vaccine.2021.05.061_b0175","doi-asserted-by":"crossref","unstructured":"Karafillakis E, Larson HJ. The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations. Vaccine [Internet]. 2017;35(37):4840\u201350. Available from: http:\/\/dx.doi.org\/10.1016\/j.vaccine.2017.07.061","DOI":"10.1016\/j.vaccine.2017.07.061"},{"key":"10.1016\/j.vaccine.2021.05.061_b0180","doi-asserted-by":"crossref","unstructured":"Miranda S, Chaignot C, Hristophe, Collin C, Dray-Spira R, Weill A, et al. Human papillomavirus vaccination and risk of autoimmune diseases: A large cohort study of over 2million young girls in France. Vaccine [Internet]. 2017 Aug 24 [cited 2020 Apr 30];35(36):4761\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28750853","DOI":"10.1016\/j.vaccine.2017.06.030"},{"key":"10.1016\/j.vaccine.2021.05.061_b0185","unstructured":"Godinot LD, Sicsic J, Lach\u00e2tre M, Abiteboul D, Rouveix E, Raude J, et al. Quantifying preferences around vaccination against frequent, mild disease with risk for vulnerable persons: A discrete choice experiment among French hospital health care workers [Internet]. 2020 Nov [cited 2020 Nov 23]. Available from: https:\/\/halshs.archives-ouvertes.fr\/halshs-03008549"},{"issue":"3","key":"10.1016\/j.vaccine.2021.05.061_b0190","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3917\/ado.077.0479","article-title":"Conduites adolescentes et d\u00e9veloppement c\u00e9r\u00e9bral : psychanalyse et neurosciences","volume":"77","author":"Dayan","year":"2011","journal-title":"Adolescence [Internet]"},{"issue":"2","key":"10.1016\/j.vaccine.2021.05.061_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088493","article-title":"Quantifying the decisional satisfaction to accept or reject the human papillomavirus (HPV) vaccine: A preference for cervical cancer prevention","volume":"9","author":"Harper","year":"2014","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.vaccine.2021.05.061_b0200","doi-asserted-by":"crossref","first-page":"e0181073","DOI":"10.1371\/journal.pone.0181073","article-title":"Adolescent values for immunisation programs in Australia: A discrete choice experiment","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One [Internet]"},{"key":"10.1016\/j.vaccine.2021.05.061_b0205","doi-asserted-by":"crossref","unstructured":"Zarbatany L, Hartmann DP, Gelfand DM, Vinciguerra P. Gender Differences in Altruistic Reputation. Are They Artifactual? Dev Psychol [Internet]. 1985 Jan [cited 2020 Jun 22];21(1):97\u2013101. Available from: \/record\/1985-14218-001","DOI":"10.1037\/\/0012-1649.21.1.97"},{"key":"10.1016\/j.vaccine.2021.05.061_b0210","doi-asserted-by":"crossref","DOI":"10.2139\/ssrn.2796221","article-title":"Gender Differences in Altruism on Mechanical Turk: Expectations and Actual Behaviour","author":"Braaas-Garza","year":"2018","journal-title":"SSRN Electron J [Internet]"},{"key":"10.1016\/j.vaccine.2021.05.061_b0215","doi-asserted-by":"crossref","unstructured":"Bonafide KE, Vanable PA. Male Human Papillomavirus Vaccine Acceptance Is Enhanced by a Brief Intervention that Emphasises Both Male-Specific Vaccine Benefits and Altruistic Motives. Sex Transm Dis [Internet]. 2015 Feb 2 [cited 2020 Jun 19];42(2):76\u201380. Available from: http:\/\/content.wkhealth.com\/linkback\/openurl?sid=WKPTLP:landingpage&an=00007435-201502000-00005","DOI":"10.1097\/OLQ.0000000000000226"},{"issue":"7","key":"10.1016\/j.vaccine.2021.05.061_b0220","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.4161\/hv.28779","article-title":"Effect of the decision-making process in the family on HPV vaccination rates among adolescents 9\u201317 years of age","volume":"10","author":"Berenson","year":"2014","journal-title":"Hum Vaccin Immunother [Internet]."},{"issue":"1","key":"10.1016\/j.vaccine.2021.05.061_b0225","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jpag.2017.10.003","article-title":"Adolescent-Parent Dyad Descriptions of the Decision to Start the HPV Vaccine Series","volume":"31","author":"Chang","year":"2018","journal-title":"J Pediatr Adolesc Gynecol [Internet]."},{"key":"10.1016\/j.vaccine.2021.05.061_b0230","doi-asserted-by":"crossref","unstructured":"Sheeran P. Intention\u2014Behavior Relations: A Conceptual and Empirical Review. Eur Rev Soc Psychol [Internet]. 2002 Jan 1 [cited 2020 Nov 19];12(1):1\u201336. Available from: https:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/14792772143000003","DOI":"10.1080\/14792772143000003"},{"key":"10.1016\/j.vaccine.2021.05.061_b0235","first-page":"339","article-title":"le groupe Barom\u00e8tre sant\u00e9 2016. Adh\u00e9sion \u00e0 la vaccination en France : r\u00e9sultats du Barom\u00e8tre sant\u00e9 2016","author":"Gautier","year":"2017","journal-title":"Bull Epidemiol Hebd"},{"key":"10.1016\/j.vaccine.2021.05.061_b0240","doi-asserted-by":"crossref","unstructured":"Marshall HS, Chen G, Clarke M, Ratcliffe J. Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: A Discrete Choice Experiment. Vaccine [Internet]. 2016 Jan 27 [cited 2020 Jul 10];34(5):671\u20137. Available from: http:\/\/dx.doi.org\/10.1016\/j.vaccine.2015.11.075","DOI":"10.1016\/j.vaccine.2015.11.075"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21006563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21006563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:58:58Z","timestamp":1759402738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21006563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":48,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0264410X21006563"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.05.061","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimising HPV vaccination communication to adolescents: A discrete choice experiment","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.05.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}